Laryngoscope investigative otolaryngology · 2025
Pyriform Plasty as an Adjunct to Septoplasty: A Double-Blind Randomized Trial in Patients With Septal Deviation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ghazizadeh Matin, Barati Behrouz, Moini Mohammad, Mansurzadeh Homeira
Аннотация
INTRODUCTION: The study was designed to compare the final long-term outcomes of septoplasty with and without unilateral pyriform plasty on the concave side in patients with septal deviation.
MATERIALS AND METHODS: A randomized clinical trial was conducted from 2020 to 2023. Patients were randomly divided into two groups of 30. The control group underwent septoplasty alone (without pyriform plasty). Septoplasty with pyriform plasty was performed for the intervention group. The patient's subjective feelings were compared using the NOSE questionnaire pre- and post-operatively. Six months after surgery, the patients were evaluated objectively using rhinomanometry.
RESULTS: The mean age of the patients was 37.07 ± 10.39 years. Based on the rhinomanometry evaluation, the amounts of airflow in the intervention and control groups were 791.23 ± 113.14 (cm3/s) and 665.44 ± 101.03 (p < 0.001), respectively. Also, the resistance level was 0.20 ± 0.04 (Pa/cm3/s) in the intervention group and 0.23 ± 0.05 (Pa/cm3/s) in the control group (p = 0.036). Among evaluated symptoms, significant improvement in nasal obstruction was detected in the intervention group (p = 0.044).
CONCLUSION: Although septoplasty improved the patient's clinical condition by increasing nasal airflow and decreasing airflow resistance, septoplasty with pyriform plasty on the concave side significantly resulted in more favorable outcomes.
LEVEL OF EVIDENCE: 2.
MATERIALS AND METHODS: A randomized clinical trial was conducted from 2020 to 2023. Patients were randomly divided into two groups of 30. The control group underwent septoplasty alone (without pyriform plasty). Septoplasty with pyriform plasty was performed for the intervention group. The patient's subjective feelings were compared using the NOSE questionnaire pre- and post-operatively. Six months after surgery, the patients were evaluated objectively using rhinomanometry.
RESULTS: The mean age of the patients was 37.07 ± 10.39 years. Based on the rhinomanometry evaluation, the amounts of airflow in the intervention and control groups were 791.23 ± 113.14 (cm3/s) and 665.44 ± 101.03 (p < 0.001), respectively. Also, the resistance level was 0.20 ± 0.04 (Pa/cm3/s) in the intervention group and 0.23 ± 0.05 (Pa/cm3/s) in the control group (p = 0.036). Among evaluated symptoms, significant improvement in nasal obstruction was detected in the intervention group (p = 0.044).
CONCLUSION: Although septoplasty improved the patient's clinical condition by increasing nasal airflow and decreasing airflow resistance, septoplasty with pyriform plasty on the concave side significantly resulted in more favorable outcomes.
LEVEL OF EVIDENCE: 2.